Product Code: ETC7549639 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India opioid receptor agonist market import shipment demonstrated significant growth momentum with a CAGR of 8.9% from 2020 to 2024. Notably, the growth rate spiked by 53.6% between 2023 and 2024, indicating a substantial expansion trend over the years, showcasing a thriving market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Opioid Receptor Agonist Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 India Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 India Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 India Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 India Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 India Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 India Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in India |
4.2.2 Growing awareness and acceptance of opioid drugs for pain management |
4.2.3 Rise in healthcare expenditure and investments in pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on opioid medications in India |
4.3.2 Concerns regarding potential misuse and addiction to opioid drugs |
4.3.3 Limited availability and accessibility of opioid medications in certain regions of India |
5 India Opioid Receptor Agonist Market Trends |
6 India Opioid Receptor Agonist Market, By Types |
6.1 India Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 India Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 India Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 India Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 India Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 India Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 India Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 India Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 India Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 India Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 India Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 India Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 India Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 India Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 India Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 India Opioid Receptor Agonist Market Export to Major Countries |
7.2 India Opioid Receptor Agonist Market Imports from Major Countries |
8 India Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of new opioid drug approvals by regulatory authorities in India |
8.2 Percentage of healthcare professionals trained in appropriate opioid prescribing practices |
8.3 Patient satisfaction scores related to pain management efficacy with opioid medications |
8.4 Number of pain clinics or specialized centers offering opioid therapy in India |
8.5 Rate of adverse events or misuse associated with opioid medications in India |
9 India Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 India Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 India Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 India Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 India Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Opioid Receptor Agonist Market - Competitive Landscape |
10.1 India Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 India Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |